Discover a New Microfluidic System from MilliporeSigma at AACR
10 Apr 2016Learn how to gain unprecedented control of your cell culture micro-environment using the new CellASIC® ONIX2 Microfluidic System.
Plus, visit MilliporeSigma at booth #528 to learn about all the latest tools for cancer research and care.
Including:
- Pre-designed & Custom CRISPRs
- Duolink® & PLA® Technology
- ELISA
- Western Blot Analysis
- Comprehensive Antibody Portfolio
- Gene Expression
- Cell Culture
- Our Exhibitor Spotlight Theater Presentation
- A schedule of our poster sessions
- Chance to win a Fitbit
About MilliporeSigma
MilliporeSigma, the U.S. life science business of Merck KGaA, Darmstadt, Germany is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. For more information, please visit www.emdgroup.com.